345 related articles for article (PubMed ID: 20507386)
41. A Korean case of anti-p200 pemphigoid.
Cho SB; Kim SC
Yonsei Med J; 2003 Oct; 44(5):931-4. PubMed ID: 14584115
[TBL] [Abstract][Full Text] [Related]
42. Ex vivo pathogenicity of anti-laminin γ1 autoantibodies.
Florea F; Bernards C; Caproni M; Kleindienst J; Hashimoto T; Koch M; Sitaru C
Am J Pathol; 2014 Feb; 184(2):494-506. PubMed ID: 24300951
[TBL] [Abstract][Full Text] [Related]
43. Case of epidermolysis bullosa acquisita with concomitant anti-laminin-332 antibodies.
Nishida E; Nishio E; Murashima H; Ishii N; Hashimoto T; Morita A
J Dermatol; 2018 Apr; 45(4):472-474. PubMed ID: 29205468
[TBL] [Abstract][Full Text] [Related]
44. Anti-p200 Pemphigoid: A Systematic Review.
Kridin K; Ahmed AR
Front Immunol; 2019; 10():2466. PubMed ID: 31695695
[TBL] [Abstract][Full Text] [Related]
45. Cicatricial pemphigoid, bullous pemphigoid, and epidermolysis bullosa acquisita antigens: differences in organ and species specificities and localization in chemically-separated human skin of three basement membrane antigens.
Fine JD
Coll Relat Res; 1985 Sep; 5(4):369-77. PubMed ID: 3902344
[TBL] [Abstract][Full Text] [Related]
46. [Anti-p200 pemphigoid: clinical, diagnostic and therapeutic aspects].
Drerup KA; Wehkamp U
Hautarzt; 2020 Feb; 71(2):130-133. PubMed ID: 31501972
[TBL] [Abstract][Full Text] [Related]
47. Identification of a novel basement membrane antigen (p84) defined by sera with antibodies to both the epidermal and dermal side of split skin.
Gao SQ; Bystryn JC
J Invest Dermatol; 1994 Feb; 102(2):236-40. PubMed ID: 8106753
[TBL] [Abstract][Full Text] [Related]
48. A novel 105-kDa lamina lucida autoantigen: association with bullous pemphigoid.
Cotell SL; Lapiere JC; Chen JD; Iwasaki T; Krusinski PA; Chan LS; Woodley DT
J Invest Dermatol; 1994 Jul; 103(1):78-83. PubMed ID: 8027584
[TBL] [Abstract][Full Text] [Related]
49. A novel immune-mediated subepidermal bullous dermatosis characterized by IgG autoantibodies to a lower lamina lucida component.
Chan LS; Cooper KD
Arch Dermatol; 1994 Mar; 130(3):343-7. PubMed ID: 8129413
[TBL] [Abstract][Full Text] [Related]
50. A subepidermal blistering disease with histopathological features of dermatitis herpetiformis and immunofluorescence characteristics of bullous pemphigoid: a novel subepidermal blistering disease or a variant of bullous pemphigoid?
Salmhofer W; Kawahara Y; Soyer HP; Kerl H; Nishikawa T; Hashimoto T
Br J Dermatol; 1997 Oct; 137(4):599-604. PubMed ID: 9390339
[TBL] [Abstract][Full Text] [Related]
51. Potential role of interleukin-17 in the pathogenesis of bullous pemphigoid.
Toosi S; Bystryn JC
Med Hypotheses; 2010 Apr; 74(4):727-8. PubMed ID: 19945799
[TBL] [Abstract][Full Text] [Related]
52. Autoimmune blistering dermatoses as systemic diseases.
Vassileva S; Drenovska K; Manuelyan K
Clin Dermatol; 2014; 32(3):364-75. PubMed ID: 24767184
[TBL] [Abstract][Full Text] [Related]
53. A patient with both bullous pemphigoid and epidermolysis bullosa acquisita: an example of intermolecular epitope spreading.
Fairley JA; Woodley DT; Chen M; Giudice GJ; Lin MS
J Am Acad Dermatol; 2004 Jul; 51(1):118-22. PubMed ID: 15243536
[TBL] [Abstract][Full Text] [Related]
54. Studies on complement deposits in epidermolysis bullosa acquisita and bullous pemphigoid.
Mooney E; Falk RJ; Gammon WR
Arch Dermatol; 1992 Jan; 128(1):58-60. PubMed ID: 1371212
[TBL] [Abstract][Full Text] [Related]
55. Anti-p200/laminin γ1 pemphigoid associated with metastatic oesophageal cancer.
Goetze S; Dumke AK; Zillikens D; Hipler UC; Elsner P
J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):e219-e221. PubMed ID: 27684497
[No Abstract] [Full Text] [Related]
56. The presence of anti-basement membrane zone antibodies in the sera of patients with non-bullous lupus erythematosus.
Ishikawa O; Zaw KK; Miyachi Y; Hashimoto T; Tanaka T
Br J Dermatol; 1997 Feb; 136(2):222-6. PubMed ID: 9068736
[TBL] [Abstract][Full Text] [Related]
57. Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita.
Woodley DT; Briggaman RA; O'Keefe EJ; Inman AO; Queen LL; Gammon WR
N Engl J Med; 1984 Apr; 310(16):1007-13. PubMed ID: 6369131
[TBL] [Abstract][Full Text] [Related]
58. The autoantigen of anti-p200 pemphigoid is an acidic noncollagenous N-linked glycoprotein of the cutaneous basement membrane.
Shimanovich I; Hirako Y; Sitaru C; Hashimoto T; Bröcker EB; Butt E; Zillikens D
J Invest Dermatol; 2003 Dec; 121(6):1402-8. PubMed ID: 14675190
[TBL] [Abstract][Full Text] [Related]
59. Case of subepidermal autoimmune bullous disease with psoriasis vulgaris reacting to both BP180 C-terminal domain and laminin gamma-1.
Ishida S; Takahashi K; Kanaoka M; Okawa T; Tateishi C; Yasukochi A; Ishii N; Li X; Hashimoto T; Aihara M
J Dermatol; 2015 Apr; 42(4):391-3. PubMed ID: 25683229
[TBL] [Abstract][Full Text] [Related]
60. Autoimmune subepidermal blistering diseases in Uganda: correlation of autoantibody class with age of patients.
Mulyowa GK; Jaeger G; Kabakyenga J; Bröcker EB; Zillikens D; Schmidt E
Int J Dermatol; 2006 Sep; 45(9):1047-52. PubMed ID: 16961507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
